2021
DOI: 10.1007/s11010-020-04037-6
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoprotein-AI and AIBP synergetic anti-inflammation as vascular diseases therapy: the new perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 115 publications
0
6
0
Order By: Relevance
“…Apolipoproteins A-IV are important components of the lipoprotein particles that transport cholesterol, triglycerides, and phospholipids through the blood from and toward different tissues. Indeed, lipoproteins have the ability to suppress inflammation, oxidative stress, tissue remodeling, and promote adaptive immunity and host defense [ 77 , 78 , 79 ]. Other proteins were observed at lower levels in the serum of T1 DS horses compared to basal or T1CTRL horses.…”
Section: Discussionmentioning
confidence: 99%
“…Apolipoproteins A-IV are important components of the lipoprotein particles that transport cholesterol, triglycerides, and phospholipids through the blood from and toward different tissues. Indeed, lipoproteins have the ability to suppress inflammation, oxidative stress, tissue remodeling, and promote adaptive immunity and host defense [ 77 , 78 , 79 ]. Other proteins were observed at lower levels in the serum of T1 DS horses compared to basal or T1CTRL horses.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, these results showed an advantageous ApoA1 effect on mediating EC survival under pathologic condition and this effect was confirmed by inhibition of the PI3K/Akt downstream cytosolic signaling pathway. Possible beneficial effects related to anti-inflammatory ApoA1 actions were discussed in recent reviews ( Jackson et al, 2021 ; Robert et al, 2021 ). However, to confirm this suggestion, proinflammatory and anti-inflammatory cytokine content in induced mBEC death before and after ApoA1 treatment needs to be elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…Numerous studies indicate that unmitigated chronic inflammation can increase the risk of various diseases, including but not limited to cancer, cardiovascular disease and various neurological disease 111 . It has been postulated that treatment regimens that decrease or attenuate inflammation may decrease the comorbidity and mortality of certain diseases 112‐114 . Consequently, there has been extensive research conducted to find and develop natural or synthetic compounds for the treatment of inflammation 115 …”
Section: Pharmacological Efficacymentioning
confidence: 99%
“…111 It has been postulated that treatment regimens that decrease or attenuate inflammation may decrease the comorbidity and mortality of certain diseases. [112][113][114] Consequently, there has been extensive research conducted to find and develop natural or synthetic compounds for the treatment of inflammation. 115 In vitro and in vivo studies have reported that the isolates or crude extracts from Ardisia species have antiinflammatory efficacy.…”
Section: Antiinflammatory Efficacymentioning
confidence: 99%